Bristol-Myers Squibb (BMY) Q2 2021 Earnings Report
MX:BMY Q2 2021 EPS Results
- Actual EPS
- MXN 36.26
- Consensus EPS
- MXN 35.43
- Beat/Miss
- Beat by +MXN 0.83
- One Year Ago EPS
- MXN 30.62
MX:BMY Q2 2021 Revenue Results
- Actual Revenue
- MXN 219.85B
- Expected Revenue
- MXN 211.70B
- Beat/Miss
- Beat by +MXN 8.16B
- YoY Revenue Growth
- +15.54%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/28/2021
- Time
- Before Open
- Conference Call
- Wednesday, July 28, 2021
MX:BMY Upcoming Earnings
Bristol-Myers Squibb's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:BMY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q4) | 28.59- | 23.67 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 20.6525.36 | 30.62 | -17.18% (-5.26) | |
| Jul 30, 2026 | 2026 (Q2) | 30.0038.32 | 27.43 | 39.73% (+10.90) | |
| Apr 30, 2026 | 2026 (Q1) | 26.7529.68 | 33.81 | -12.22% (-4.13) | |
| Feb 05, 2026 | 2025 (Q4) | 23.0323.67 | 31.37 | -24.55% (-7.70) | |
| Oct 30, 2025 | 2025 (Q3) | 28.5230.62 | 33.81 | -9.44% (-3.19) | |
| Aug 01, 2025 | 2025 (Q2) | 20.5027.43 | 38.89 | -29.47% (-11.46) | |
| Apr 24, 2025 | 2025 (Q1) | 28.0933.81 | -82.66 | 140.91% (+116.47) | |
| Feb 06, 2025 | 2024 (Q4) | 27.4831.37 | 31.94 | -1.76% (-0.56) | |
| Oct 31, 2024 | 2024 (Q3) | 28.0733.81 | 37.57 | -10.00% (-3.76) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed